07.09.2011Augurix and Tillotts sign agreement for the commercialization of Simtomax.

You are here

Augurix and Tillotts sign agreement for the commercialization of Simtomax.

Augurix and Tillotts sign agreement for the commercialization of Simtomax® for rapid diagnosis of celiac disease.

View PDF

Find on a map Advanced search

BioAlps World Visibitlity Package 201918.03.2019

A yearly international programme for our affiliated companies to increase their visibility.

Debiopharm Diagnostic SAR&D Services and Technology Platforms, Diagnostic Instrumentation / Analytical Services

Print this page

Download this page (PDF)

Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn

Powered by /boomerang